Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Olema Pharmaceuticals
(NASDAQ:OLMA)
Intraday
$9.83
0
[0.00%]
After-Hours
$9.83
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$9.83
0
[0.00%]
At close: Apr 25
$9.83
0
[0.00%]
PreMarket: 4:03PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Olema Pharmaceuticals Stock (NASDAQ:OLMA)
Olema Pharmaceuticals Stock (NASDAQ: OLMA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 02, 2024
Goldman Sachs Initiates Coverage On Olema Pharmaceuticals with Buy Rating, Announces Price Target of $24
Benzinga Newsdesk
-
Apr 2, 2024, 7:09AM
Tuesday, March 12, 2024
Oppenheimer Reiterates Outperform on Olema Pharmaceuticals, Maintains $21 Price Target
Benzinga Newsdesk
-
Mar 12, 2024, 8:18AM
HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $25
Benzinga Newsdesk
-
Mar 12, 2024, 6:39AM
Monday, March 11, 2024
Olema Pharmaceuticals Q4 EPS $(0.49) Misses $(0.48) Estimate
Happy Mohamed
-
Mar 11, 2024, 4:04PM
Thursday, February 01, 2024
Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
-
Feb 1, 2024, 10:46AM
Wednesday, January 31, 2024
Olema Pharmaceuticals Filed Prospectus Related To Resale Of Up To 13.2M Shares Of Common Stock Held By Selling Stockholders
Charles Gross
-
Jan 31, 2024, 4:24PM
Tuesday, January 30, 2024
Citigroup Initiates Coverage On Olema Pharmaceuticals with Buy Rating, Announces Price Target of $20
Benzinga Newsdesk
-
Jan 30, 2024, 7:33AM
Monday, January 08, 2024
Olema Oncology Nominates OP-3136 As A Development Candidate
Benzinga Newsdesk
-
Jan 8, 2024, 8:14AM
Tuesday, December 19, 2023
$6.9M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
-
Dec 19, 2023, 6:59AM
Monday, December 11, 2023
Insiders Buying Walt Disney And 3 Other Stocks
Avi Kapoor
-
Dec 11, 2023, 7:17AM
Tuesday, December 05, 2023
Olema Pharmaceuticals shares are trading lower after the company announced interim results from an ongoing Phase 1b/2 clinical study of palazestrant in combination with CDK4/6 inhibitor ribociclib.
Benzinga Newsdesk
-
Dec 5, 2023, 12:54PM
Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability With CDK4/6 Inhibitors Ribociclib And Palbociclib In Phase 1b/2 Studies
Benzinga Newsdesk
-
Dec 5, 2023, 12:36PM
Tuesday, November 28, 2023
Olema Oncology To Present New Palazestrant Clinical Data In Combination With CDK4/6 Inhibitors At 2023 San Antonio Breast Cancer Symposium
Benzinga Newsdesk
-
Nov 28, 2023, 5:11PM
Monday, November 27, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Nov 27, 2023, 8:06AM
Tuesday, November 07, 2023
Olema Pharmaceuticals Q3 EPS $(0.48) Beats $(0.51) Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 5:08PM
Monday, November 06, 2023
TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday
Lisa Levin
-
Nov 6, 2023, 10:27AM
Sunday, October 22, 2023
Olema Oncology Earlier Announced Phase 2 Monotherapy Clinical Study Results For Palazestrant; Showed Results Support Continued Development Of Palazestrant In The OPERA-01 Monotherapy Phase 3 Pivotal Trial
Charles Gross
-
Oct 22, 2023, 11:11AM
Tuesday, October 17, 2023
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Oct 17, 2023, 11:40AM
Monday, October 16, 2023
Olema Oncology Announces Phase 2 Monotherapy Clinical Results Of Palazestrant For Metastatic Breast Cancer To Be Presented At The 2023 ESMO Congress
Benzinga Newsdesk
-
Oct 16, 2023, 7:14AM
Thursday, October 12, 2023
Olema Pharmaceuticals Announced New Preclinical Data Regarding The Discovery Of Novel Compounds Targeting KAT6, An Epigenetic Target That Is Dysregulated In Breast And Other Cancers
Benzinga Newsdesk
-
Oct 12, 2023, 7:03AM
Wednesday, October 11, 2023
Analyst Ratings for Olema Pharmaceuticals
Benzinga Insights
-
Oct 11, 2023, 1:01PM
HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $28 Price Target
Benzinga Newsdesk
-
Oct 11, 2023, 7:46AM
Tuesday, October 10, 2023
Olema Oncology Enters Expansion Of Collaboration Agreement With Novartis
Benzinga Newsdesk
-
Oct 10, 2023, 7:06AM
Thursday, September 21, 2023
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Sep 21, 2023, 1:35PM
Wednesday, September 20, 2023
Olema Pharmaceuticals Announced Poster Presentation On New Discovery Compounds Targeting KAT6, An Epigenetic Target Dysregulated In Breast And Other Cancers At The 2023 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics
Benzinga Newsdesk
-
Sep 20, 2023, 7:32AM
Friday, September 15, 2023
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Sep 15, 2023, 12:40PM
Director of Olema Pharmaceuticals Purchased $14.82M In Stock
Benzinga Insights
-
Sep 15, 2023, 11:05AM
JP Morgan Maintains Overweight on Olema Pharmaceuticals, Raises Price Target to $19
Benzinga Newsdesk
-
Sep 15, 2023, 10:16AM
Wednesday, September 06, 2023
Oppenheimer Reiterates Outperform on Olema Pharmaceuticals, Maintains $21 Price Target
Benzinga Newsdesk
-
Sep 6, 2023, 7:32AM
Tuesday, September 05, 2023
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Sep 5, 2023, 1:34PM
Olema Pharmaceuticals shares are trading higher after the company announced a private placement and a senior-secured credit facility for combined financing of up to $180 million.
Benzinga Newsdesk
-
Sep 5, 2023, 1:00PM
Where Olema Pharmaceuticals Stands With Analysts
Benzinga Insights
-
Sep 5, 2023, 1:00PM
HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Raises Price Target to $28
Benzinga Newsdesk
-
Sep 5, 2023, 12:12PM
Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Sep 5, 2023, 10:43AM
Olema Pharmaceuticals Announced A Private Placement Of Approximately $130M, It Will Issue 13.2M Shares At $9.84/Share; The Company Also Announced A New Senior-secured Credit Facility Of Up To $50M
Benzinga Newsdesk
-
Sep 5, 2023, 7:35AM
Thursday, August 10, 2023
The Latest Analyst Ratings for Olema Pharmaceuticals
Benzinga Insights
-
Aug 10, 2023, 3:00PM
JP Morgan Maintains Overweight on Olema Pharmaceuticals, Raises Price Target to $16
Benzinga Newsdesk
-
Aug 10, 2023, 12:41PM
Wednesday, August 09, 2023
Credit Suisse Maintains Outperform on Olema Pharmaceuticals, Raises Price Target to $18
Benzinga Newsdesk
-
Aug 9, 2023, 9:29AM
HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Raises Price Target to $22
Benzinga Newsdesk
-
Aug 9, 2023, 6:43AM
Tuesday, August 08, 2023
Olema Pharmaceuticals Q2 EPS $(0.49) Beats $(0.73) Estimate
Benzinga Newsdesk
-
Aug 8, 2023, 5:19PM
Friday, July 21, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
Benzinga Insights
-
Jul 21, 2023, 11:00AM
Oppenheimer Initiates Coverage On Olema Pharmaceuticals with Outperform Rating, Announces Price Target of $21
Benzinga Newsdesk
-
Jul 21, 2023, 4:51AM
Thursday, June 29, 2023
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
Lisa Levin
-
Jun 29, 2023, 11:23AM
Thursday, June 22, 2023
Board Member at Olema Pharmaceuticals Acquires Company Stock Options Worth 21,520 Shares
Benzinga Insights
-
Jun 22, 2023, 11:02AM
Tuesday, June 20, 2023
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Jun 20, 2023, 1:07PM
DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Jun 20, 2023, 10:22AM
Friday, June 16, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Jun 16, 2023, 1:32PM
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Jun 16, 2023, 1:08PM
Coherus BioSciences, MicroVision, Millicom And Other Big Stocks Moving Lower On Friday
Lisa Levin
-
Jun 16, 2023, 10:37AM
Monday, June 12, 2023
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Jun 12, 2023, 1:03PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch